CT and MRI of the liver for hepatocellular carcinoma

Cynthia Santillan

Hepatoma Research ›› 2020, Vol. 6 : 63

PDF
Hepatoma Research ›› 2020, Vol. 6:63 DOI: 10.20517/2394-5079.2020.60
Review
Review

CT and MRI of the liver for hepatocellular carcinoma

Author information +
History +
PDF

Abstract

Computed tomography (CT) and magnetic resonance imaging (MRI) are commonly used modalities for the imaging based diagnosis and staging of hepatocellular carcinoma (HCC). The Liver Imaging Reporting and Data System (LI-RADS) was initially released in 2011 in an effort to standardize the interpretation and reporting of these studies in patients at increased risk for the development of HCC. With the release of LI-RADS v2018, LI-RADS has reached two important milestones - 10 years since the formation of the American College of Radiology supported LI-RADS committee and integration of LI-RADS into the 2018 American Association for the Study of Liver Disease practice guidance for HCC. In this article, we will discuss recent changes to LI-RADS with v2018, technical recommendations for the performance of CT and MRI in patients at risk for HCC, and critical imaging features in the LI-RADS algorithm.

Keywords

Hepatocellular carcinoma / Liver Imaging Reporting and Data System / magnetic resonance imaging / computed tomography

Cite this article

Download citation ▾
Cynthia Santillan. CT and MRI of the liver for hepatocellular carcinoma. Hepatoma Research, 2020, 6: 63 DOI:10.20517/2394-5079.2020.60

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Elsayes KM,Chernyak V,Furlan A.LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance..J Hepatocell Carcinoma2019;6:49-69 PMCID:PMC6368120

[2]

Sirlin CB.The LI-RADS adventure-a personal statement..Abdom Radiol (NY)2018;43:1-2

[3]

Chernyak V,Papadatos D.LI-RADS® algorithm: CT and MRI..Abdom Radiol (NY)2018;43:111-26

[4]

American College of Radiology. Liver Imaging Reporting and Data System version 2018. Available from: http://www.acr.org/Quality-Safety/Resources/LIRADS. [Last accessed on 12 Aug 2020]

[5]

Kambadakone AR,Gupta RT,Fowler KJ.LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound..Abdom Radiol (NY)2018;43:56-74

[6]

Ichikawa T,Nakajima H,Tsukamoto T.Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?.AJR Am J Roentgenol2002;179:751-8

[7]

Choi JY,Sirlin CB.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features..Radiology2014;273:30-50 PMCID:PMC4263770

[8]

Chernyak V,Flusberg M,Bijan B.LI-RADS® ancillary features on CT and MRI..Abdom Radiol (NY)2018;43:82-100

[9]

Matsui O,Sanada J,Ryu Y.Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis..Abdom Imaging2011;36:264-72 PMCID:PMC3102849

[10]

Muto J,Sugimachi K.Review of angiogenesis in hepatocellular carcinoma..Hepatol Res2015;45:1-9

[11]

Fowler KJ,Hope TA,Wilson SR.LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma..Abdom Radiol (NY)2018;43:149-57

[12]

Pawlik TM,Vauthey JN,Ng IO.Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma..Liver Transpl2005;11:1086-92

[13]

Forner A,Ayuso C,Solé M.Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma..Hepatology2008;47:97-104

[14]

Kelekis NL,Worawattanakul S,Ascher SM.Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images..AJR Am J Roentgenol1998;170:1005-13

[15]

Freeny PC,Teefey SA.Hepatocellular carcinoma: reduced frequency of typical findings with dynamic contrast-enhanced CT in a non-Asian population..Radiology1992;182:143-8

[16]

Kadoya M,Takashima T.Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings..Radiology1992;183:819-25

[17]

Choi JY,Sirlin CB.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects..Radiology2014;272:635-54 PMCID:PMC4263631

[18]

Kielar AZ,Bashir MR,Fowler KJ.An update for LI-RADS: Version 2018. Why so soon after version 2017?.J Magn Reson Imaging2019;50:1990-1

PDF

62

Accesses

0

Citation

Detail

Sections
Recommended

/